Disease/Infection News

RSS

New study highlights burden of community-acquired pneumonia hospitalizations among U.S. adults

Viruses, not bacteria, are the most commonly detected respiratory pathogens in U.S. adults hospitalized with pneumonia, according to a New England Journal of Medicine study released today and conducted by researchers at Centers for Disease Control and Prevention and hospitals in Chicago and Nashville, including Vanderbilt University Medical Center.

15 Jul 2015

Only two states in U.S. require HPV vaccination

An examination of state vaccination requirements for adolescents finds that the human papillomavirus (HPV) vaccine is currently required in only two states, many fewer than another vaccine associated with sexual transmission (hepatitis B) and another primarily recommended for adolescents (meningococcal conjugate), according to a study in the July 14 issue of JAMA.

15 Jul 2015

Ebola vaccine study begins in Dakar, Senegal

A trial to evaluate an Ebola vaccine has begun in Dakar, Senegal, after initial immunisations started at the Jenner Institute, Oxford University. The announcement comes as a conference in Oxford discusses the global response to Ebola and the implications for future drug and vaccine development.

15 Jul 2015

New report highlights key success in global response to preventing AIDS in women, children

The Elizabeth Glaser Pediatric AIDS Foundation applauds today's announcement from the Joint United Nations Programme on HIV/AIDS that the goal of providing 15 million people with lifesaving antiretroviral therapy (ART) by 2015 has been met nine months ahead of schedule.

14 Jul 2015

Multidrug-resistant bacteria can naturally relinquish its ability to resist antibiotics

Infections with one of the most troublesome and least understood antibiotic-resistant "superbugs" are increasing at alarming rates, particularly in health-care settings.

14 Jul 2015

New approach provides more complete picture of donor support for key global health issues

As the world's leaders gather in Addis Ababa, Ethiopia, for the Financing for Development Conference, a study published in The Lancet demonstrates that a new approach is needed for classifying funding that reflects the function the funding serves, rather than the specific disease or country. The study is the first in-depth assessment of how donor funding is spent on global versus country-specific functions of health.

14 Jul 2015

VUMC becomes Human Vaccines Project's first scientific hub

Vanderbilt University Medical Center, the Human Vaccines Project and the International AIDS Vaccine Initiative are pleased to announce that VUMC has become the Project's first scientific hub.

14 Jul 2015

Researchers discover role of RORC mutations in patients with candidiasis and mycobacteriosis

The discovery of bi-allelic mutations in RORC in patients with candidiasis and mycobacteriosis revealed the pivotal role of RORC in mucocutaneous immunity to Candida and in systemic immunity to Mycobacterium in humans.

13 Jul 2015

Cysticercosis now fully controlled in Mexico

Dr. Ana Flisser was recognized for 40 years of research regarding this disease. The parasite can not be eradicated; however, it is important to present simple preventive measures.

13 Jul 2015

Experts call for more spending on global health aids

As experts debate the slow response to the Ebola outbreak in West Africa and call for better international coordination, a new analysis estimates that $22 billion was spent on global health aid in 2013, yet only a fifth of this went toward such global imperatives as research on diseases that disproportionally affect the poor, outbreak preparedness and global health leadership.

13 Jul 2015

Barbara Murray recognized by Association of Rice Alumni for contributions to infectious disease research

Barbara Murray, M.D., director of the Division of Infectious Diseases at The University of Texas Health Science Center at Houston Medical School, was recognized by the Association of Rice Alumni at its Laureates Dinner May 16.

12 Jul 2015

Researchers reveal how certain lipids help adenoviruses to enter the cell

Adenoviruses cause numerous diseases, such as eye or respiratory infections, and they are widely used in gene therapy. Researchers from the University of Zurich have now discovered how these viruses penetrate the cells, a key step for infection and gene delivery. The cell unwillingly supports virus entry and infection by providing lipids that are normally used to repair damaged membranes.

10 Jul 2015

UTHealth scientist receives $1.9 million from NIH to develop non-antibiotic treatment for C. diff infections

Charles Darkoh, Ph.D., a researcher at The University of Texas Health Science Center at Houston School of Public Health, was recently awarded a five-year, $1.9 million R01 grant by the National Institutes of Health to develop a non-antibiotic treatment for Clostridium difficile (C. diff) infections.

10 Jul 2015

Starting anti-HIV treatment early improves survival among patients with newly diagnosed TB

Starting anti-HIV treatment within two weeks of the diagnosis of tuberculosis, or TB, improved survival among patients with both infections who had very low immune-cell counts, according to an analysis by researchers at the University of Pittsburgh Graduate School of Health.

10 Jul 2015

Faith-based health providers crucial in achieving universal health coverage for poor, marginalised people

Faith-based organisations are crucial in achieving the promise of universal health coverage—an adequate standard of health care for all people—especially for poor and marginalised groups, according to a new three-part Series on faith-based health care, published in The Lancet.

10 Jul 2015

Trial results show routine oral cholera vaccination programme protects people living in endemic regions

An oral cholera vaccine given as part of routine health services is safe and protects against severe cholera in children and adults in urban Bangladesh where the disease is endemic, according to the first real-life trial of this vaccine published in The Lancet.

10 Jul 2015

TSRI study reveals alternative approach to current anti-HIV strategies

HIV-infected patients remain on antiretroviral therapy for life because the virus survives over the long-term in infected dormant cells. Interruption of current types of antiretroviral therapy results in a rebound of the virus and clinical progression to AIDS.

9 Jul 2015

Study analyzes attitudes and practices of general physicians in different vaccination scenarios

At population level, vaccines contribute to reducing mortality associated with infectious diseases such as measles, diphtheria, tetanus, hepatitis B or bacterial meningitis.

9 Jul 2015

Three South Florida research centers receive Campbell Foundation grants for HIV/AIDS studies

New research is taking place all around the world in the fight to find a cure for AIDS. But did you know that some critical research is taking place in our own backyard? That’s why The Campbell Foundation recently provided three South Florida research centers each with $30,000 fast-track grants to assist them with their ground-breaking investigations.

9 Jul 2015

Vanderbilt investigators develop potential antibody treatments against chikungunya

In late 2013 the Caribbean had its first case of the mosquito-borne chikungunya virus. Today there have been almost 1.2 million cases in 44 countries or territories, including 177 cases in 31 U.S. States. Vanderbilt University Medical Center's James Crowe, M.D., Ann Scott Carell Professor and director of the Vanderbilt Vaccine Center, and his team are reporting the first large panel of antibody treatments against this disease in the current issue of Cell Host and Microbe.

9 Jul 2015

Disease/Infection News

New study highlights burden of community-acquired pneumonia hospitalizations among U.S. adults

Only two states in U.S. require HPV vaccination

Ebola vaccine study begins in Dakar, Senegal

New report highlights key success in global response to preventing AIDS in women, children

Multidrug-resistant bacteria can naturally relinquish its ability to resist antibiotics

New approach provides more complete picture of donor support for key global health issues

VUMC becomes Human Vaccines Project's first scientific hub

Researchers discover role of RORC mutations in patients with candidiasis and mycobacteriosis

Cysticercosis now fully controlled in Mexico

Experts call for more spending on global health aids

Barbara Murray recognized by Association of Rice Alumni for contributions to infectious disease research

Researchers reveal how certain lipids help adenoviruses to enter the cell

UTHealth scientist receives $1.9 million from NIH to develop non-antibiotic treatment for C. diff infections

Starting anti-HIV treatment early improves survival among patients with newly diagnosed TB

Faith-based health providers crucial in achieving universal health coverage for poor, marginalised people

Trial results show routine oral cholera vaccination programme protects people living in endemic regions

TSRI study reveals alternative approach to current anti-HIV strategies

Study analyzes attitudes and practices of general physicians in different vaccination scenarios

Three South Florida research centers receive Campbell Foundation grants for HIV/AIDS studies

Vanderbilt investigators develop potential antibody treatments against chikungunya

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News